327 related articles for article (PubMed ID: 11586035)
1. Effect of cellular DNA content on the prognosis of epithelial ovarian cancers.
Ozalp S; Yalcin OT; Gulbas Z; Tanir HM; Minsin T
Gynecol Obstet Invest; 2001; 52(2):93-7. PubMed ID: 11586035
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of DNA content in epithelial ovarian cancer.
Gajewski WH; Fuller AF; Pastel-Ley C; Flotte TJ; Bell DA
Gynecol Oncol; 1994 Apr; 53(1):5-12. PubMed ID: 8175021
[TBL] [Abstract][Full Text] [Related]
3. The role of DNA flow cytometry in borderline malignant ovarian tumors.
Lai CH; Hsueh S; Chang TC; Tseng CJ; Huang KG; Chou HH; Chen SM
Cancer; 1996 Aug; 78(4):794-802. PubMed ID: 8756374
[TBL] [Abstract][Full Text] [Related]
4. Flow cytometric analysis of nuclear DNA content in patients with recurrent epithelial ovarian cancer.
Hamaguchi K; Nishimura H; Tateno N; Yakushiji M; Yokoyama MM
Nihon Gan Chiryo Gakkai Shi; 1990 Dec; 25(12):2836-42. PubMed ID: 2074393
[TBL] [Abstract][Full Text] [Related]
5. Ovarian tumors of low malignant potential. Correlation of DNA index and S-phase fraction with histopathologic grade and clinical outcome.
Demirel D; Laucirica R; Fishman A; Owens RG; Grey MM; Kaplan AL; Ramzy I
Cancer; 1996 Apr; 77(8):1494-500. PubMed ID: 8608534
[TBL] [Abstract][Full Text] [Related]
6. Flow cytometric DNA ploidy and S-phase heterogeneity in advanced ovarian carcinoma.
Kaern J; Tropé CG; Kristensen GB; Pettersen EO
Cancer; 1994 Apr; 73(7):1870-7. PubMed ID: 8137213
[TBL] [Abstract][Full Text] [Related]
7. DNA index reflects the biological behavior of ovarian carcinoma stage I-IIa.
Schueler JA; Trimbos JB; vd Burg M; Cornelisse CJ; Hermans J; Fleuren GJ
Gynecol Oncol; 1996 Jul; 62(1):59-66. PubMed ID: 8690293
[TBL] [Abstract][Full Text] [Related]
8. Multivariate analysis of the prognostic significance of DNA-ploidy and S-phase fraction in ovarian cancer determined by flow cytometry following detection of cytokeratin-labeled tumor cells.
Kimmig R; Wimberger P; Hillemanns P; Kapsner T; Caspari C; Hepp H
Gynecol Oncol; 2002 Jan; 84(1):21-31. PubMed ID: 11748971
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of DNA ploidy status in patients with rectal cancer.
Berczi C; Bocsi J; Bartha I; Math J; Balazs G
Anticancer Res; 2002; 22(6B):3737-41. PubMed ID: 12552986
[TBL] [Abstract][Full Text] [Related]
10. The prognostic significance of nuclear DNA content in malignant epithelial tumors of the ovary.
Brescia RJ; Barakat RA; Beller U; Frederickson G; Suhrland MJ; Dubin N; Demopoulos RI
Cancer; 1990 Jan; 65(1):141-7. PubMed ID: 2293860
[TBL] [Abstract][Full Text] [Related]
11. P53 protein expression and DNA ploidy in common epithelial tumors of the ovary.
Ioakim-Liossi A; Karakitsos P; Aroni K; Delivelioti K; Fotiou V; Fotiou S; Kyrkou K
Acta Cytol; 1997; 41(6):1714-8. PubMed ID: 9390130
[TBL] [Abstract][Full Text] [Related]
12. DNA content in juvenile granulosa cell tumors of the ovary: a study of early- and advanced-stage disease.
Jacoby AF; Young RH; Colvin RB; Flotte TJ; Preffer F; Scully RE; Swymer CM; Bell DA
Gynecol Oncol; 1992 Jul; 46(1):97-103. PubMed ID: 1634146
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathologic variables, operative characteristics, and DNA ploidy in predicting outcome in ovarian epithelial carcinoma.
Rice LW; Mark SD; Berkowitz RS; Goff BA; Lage JM
Obstet Gynecol; 1995 Sep; 86(3):379-85. PubMed ID: 7651646
[TBL] [Abstract][Full Text] [Related]
14. Clinical value of morphometric and DNA flow cytometric variables as independent predictors of survival in epithelial ovarian carcinoma: a 5-year follow-up study.
Veerman MM; van der Wurff AA; van de Water M; Kruitwagen RF; Feijen HW; Vos MC
Int J Gynecol Pathol; 2009 Sep; 28(5):432-41. PubMed ID: 19696612
[TBL] [Abstract][Full Text] [Related]
15. Intratumoral DNA heterogeneity correlated with lymph node involvement and surgical staging in epithelial ovarian cancer by flow cytometry.
Takahashi Y; Takenaka A; Ishiguro T; Noda Y
Cancer; 1994 Jun; 73(12):3011-4. PubMed ID: 8199997
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of deoxyribonucleic acid ploidy and S-phase fraction as prognostic parameters in advanced epithelial ovarian carcinoma: a prospective study.
Kaern J; Tropé CG; Kristensen GB; Tveit KM; Pettersen EO
Am J Obstet Gynecol; 1994 Feb; 170(2):479-87. PubMed ID: 8116701
[TBL] [Abstract][Full Text] [Related]
17. The prognostic significance of stage, tumor size, cellular atypia and DNA ploidy in uterine leiomyosarcoma.
Nordal RR; Kristensen GB; Kaern J; Stenwig AE; Pettersen EO; Tropé CG
Acta Oncol; 1995; 34(6):797-802. PubMed ID: 7576748
[TBL] [Abstract][Full Text] [Related]
18. Ploidy analysis of epithelial ovarian cancers using image cytometry.
Berchuck A; Boente MP; Kerns BJ; Kinney RB; Soper JT; Clarke-Pearson DL; Bast RC; Bacus SS
Gynecol Oncol; 1992 Jan; 44(1):61-5. PubMed ID: 1370427
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of tumor ploidy in patients with advanced ovarian carcinoma.
Khoo SK; Hurst T; Kearsley J; Dickie G; Free K; Parsons PG; Whitaker S; Ward B
Gynecol Oncol; 1990 Dec; 39(3):284-8. PubMed ID: 2258072
[TBL] [Abstract][Full Text] [Related]
20. DNA ploidy pattern in papillary renal cell carcinoma. Correlation with clinicopathological parameters and survival.
del Vecchio MT; Lazzi S; Bruni A; Mangiavacchi P; Cevenini G; Luzi P
Pathol Res Pract; 1998; 194(5):325-33. PubMed ID: 9651945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
